This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cowan, C. L. Articles by Steffen, R. P. Search for Related Content PubMed PubMed Citation Articles by Cowan, C. L. Articles by Steffen, R. P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE 12-O-TETRADECANOYLPHORBOL-13-ACETATE NITRIC OXIDE

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:2290-2297.)
© 1995 American Heart Association, Inc.

Articles

Lysophosphatidylcholine Inhibits Relaxation of Rabbit Abdominal Aorta Mediated by Endothelium-Derived Nitric Oxide and Endothelium-Derived Hyperpolarizing Factor Independent of Protein Kinase C Activation

Conrad L. Cowan; Robert P. Steffen

From the Division of Biochemistry, Glaxo Wellcome Research and Development, Research Triangle Park, NC.

Correspondence to Conrad L. Cowan, PhD, Department of Receptor Biochemistry, Glaxo Wellcome Research and Development, 5 Moore Dr, Research Triangle Park, NC.

Abstract Hypercholesterolemia is associated with increased oxidized LDL and impaired endothelium-dependent relaxation (EDR). An inhibitory component of oxidized LDL is lysophosphatidylcholine (LPC). To determine the effect and mechanism(s) of action of LPC on EDR mediated by endothelium-derived nitric oxide (EDNO) and endothelium-derived hyperpolarizing factor (EDHF), rabbit abdominal aortic rings were suspended for measurement of isometric tension and studied under three conditions: control; with 25 mmol/L K⁺ buffer to isolate relaxation mediated by EDNO; and in rings treated with N-nitro-L-arginine methyl ester (L-NAME, 30 µmol/L) to isolate relaxation mediated by EDHF. Incubation with LPC (10 and 30 µmol/L) for 30 minutes inhibited EDR in a concentration-dependent manner. LPC (30 µmol/L) significantly inhibited maximal relaxation to acetylcholine in control, 25 mmol/L K⁺–, and L-NAME–treated rings (77.1±7.8%, 42.1±8.9%, and 3.4±7.7%) compared with untreated rings (99.0±0.9%, 90.9±2.2%, and 54.7±4.7%, P<.05). Inhibition of relaxation was specific to endothelium-dependent responses in that relaxation to direct smooth muscle vasodilators (papaverine, 8-bromo-cGMP, and sodium nitroprusside) were unaltered by LPC. The inhibition by LPC (30 µmol/L) was not due to cytotoxicity, because EDR returned to normal levels after repeated washing with physiological salt solution containing 0.1% albumin. Coincubation with protein kinase C inhibitors, staurosporine (20 nmol/L) or calphostin C (1 µmol/L), had no effect on the EDR inhibition by LPC (30 µmol/L). Furthermore, LPC continued to inhibit EDR in rings in which protein kinase C was downregulated by incubation for 18 hours with 1 µmol/L phorbol 12-myristate 13-acetate (PMA). The inhibition of EDR to the receptor-independent agonist A23187 by LPC (30 µmol/L) but not by PMA (30 nmol/L) further supports a lack of effect of LPC on protein kinase C. Thus, the inhibitory effect of LPC on EDR is not limited to EDNO but also inhibits relaxation mediated by EDHF. Also, the inhibition of relaxation to EDNO and EDHF is not mediated by activation of protein kinase C.

Key Words: endothelium-derived nitric oxide • rabbit • endothelium-derived hyperpolarizing factor • protein kinase C • lysophosphatidylcholine

This article has been cited by other articles:

				D. A. Zisman, S. M. Kawut, D. J. Lederer, J. A. Belperio, J. P. Lynch III, M. I. Schwarz, J. A. Tayek, D. B. Reuben, and A. S. Karlamangla Serum Albumin Concentration and Waiting List Mortality in Idiopathic Interstitial Pneumonia Chest, April 1, 2009; 135(4): 929 - 935. [Abstract] [Full Text] [PDF]

				R. Zhang, B. Rodrigues, and K. M. MacLeod Lysophosphatidylcholine Potentiates Phenylephrine Responses in Rat Mesenteric Arterial Bed through Modulation of Thromboxane A2 J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 355 - 361. [Abstract] [Full Text] [PDF]

				R. W. Jeremy and H. McCarron Effect of hypercholesterolemia on Ca2+-dependent K+ channel-mediated vasodilatation in vivo Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1600 - H1608. [Abstract] [Full Text] [PDF]

				S. Parthasarathy, N. Santanam, S. Ramachandran, and O. Meilhac Oxidants and antioxidants in atherogenesis: an appraisal J. Lipid Res., December 1, 1999; 40(12): 2143 - 2157. [Abstract] [Full Text] [PDF]

				M. Romano, E. Romano, S. Bjorkerud, and E. Hurt-Camejo Ultrastructural Localization of Secretory Type II Phospholipase A2 in Atherosclerotic and Nonatherosclerotic Regions of Human Arteries Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 519 - 525. [Abstract] [Full Text] [PDF]

				D. A. Cox and M. L. Cohen Relationship between Phospholipase D Activation and Endothelial Vasomotor Dysfunction in Rabbit Aorta J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 305 - 311. [Abstract] [Full Text]

				E. Hurt-Camejo, S. Andersen, R. Standal, B. Rosengren, P. Sartipy, E. Stadberg, and B. Johansen Localization of Nonpancreatic Secretory Phospholipase A2 in Normal and Atherosclerotic Arteries: Activity of the Isolated Enzyme on Low-Density Lipoproteins Arterioscler. Thromb. Vasc. Biol., February 1, 1997; 17(2): 300 - 309. [Abstract] [Full Text]